述评

侵蚀性骨关节炎:一种值得关注的疾病

  • 栗占国 ,
  • 任立敏
展开
栗占国,教授,主任医师,博士生导师,北京大学人民医院临床免疫中心主任,风湿免疫研究所所长,北京大学临床免疫中心主任。国家杰出青年基金获得者,973首席科学家, 吴杨医学奖和北京大学国华杰出学者奖获得者。
中国免疫学会临床免疫分会主任委员,中华医学会风湿病学分会前任主委,国际风湿病联盟和亚太风湿病联盟前主席,WHO骨与肌肉疾病委员会委员。Rheumatology Autoimmunity和《中华风湿病学杂志》主编, Clinical Rheumatology及《北京大学学报(医学版)》副主编, Lancet RheumatologyNature Reviews Rheumatology等期刊编委。
长期从事风湿免疫病临床工作,主要研究方向为类风湿关节炎、系统性红斑狼疮和干燥综合征等的发病机制及免疫治疗。在Nature MedicineScienceNature Communications等发表SCI论文380余篇,入选爱思唯尔中国高被引学者。主编(译)《类风湿关节炎》《风湿免疫学高级教程》等风湿病学专著30余部

收稿日期: 2022-06-10

  网络出版日期: 2022-10-14

本文引用格式

栗占国 , 任立敏 . 侵蚀性骨关节炎:一种值得关注的疾病[J]. 北京大学学报(医学版), 2022 , 54(5) : 829 -831 . DOI: 10.19723/j.issn.1671-167X.2022.05.008

参考文献

1 Favero M , Belluzzi E , Ortolan A , et al. Erosive hand osteoarthritis: latest findings and outlook[J]. Nat Rev Rheumatol, 2022, 18 (3): 171- 183.
2 Cavasin F , Punzi F , Ramonda R , et al. Prevalence of erosive osteoarthritis of the hand in a population from Venetian area[J]. Reumatismo, 2004, 56 (1): 46- 50.
3 Kwok WY , Kloppenburg M , Marshall M , et al. Comparison of clinical burden between patients with erosive hand osteoarthritis and inflammatory arthritis in symptomatic community-dwelling adults: the Keele clinical assessment studies[J]. Rheumatology, 2013, 52 (12): 2260- 2267.
4 Marshall M , Peat G , Nicholls E , et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years[J]. Osteoarthritis Cartilage, 2013, 21 (11): 1674- 1684.
5 张晓盈, 郅新, 穆荣, 等. 侵蚀性手骨关节炎的临床及影像学特征分析[J]. 中华风湿病杂志, 2017, 21 (7): 455- 460.
6 Punzi L , Ramonda R , Sfriso P . Erosive osteoarthritis[J]. Best Pract Res Clin Rheumatol, 2004, 18 (5): 739- 758.
7 Wittoek R , Cruyssen BV , Verbruggen G . Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis[J]. Arthritis Rheum, 2012, 64 (5): 1430- 1436.
8 Haugen IK , Mathiessen A , Slatkowsky-Christensen B , et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype[J]. Osteoarthritis Cartilage, 2016, 24 (4): 647- 654.
9 Gazeley DJ , Yeturi S , Patel PJ , et al. Erosive osteoarthritis: a systematic analysis of definitions used in the literature[J]. Semin Arthritis Rheum, 2017, 46 (4): 395- 403.
10 Stern AG , de Carvalho MRC , Buck GA , et al. Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta[J]. Osteoarthritis Cartilage, 2003, 11 (6): 394- 402.
11 Ramonda R , Musacchio E , Campana C , et al. Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy[J]. Scand J Rheumatol, 2011, 40 (2): 139- 144.
12 Kedor C , Detert J , Rau R , et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OATREAT study: a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial[J]. RMD Open, 2021, 7 (2): e001660.
13 Ferrero S , Wittoek R , Allado E , et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial[J]. Semin Arthritis Rheum, 2021, 51 (4): 831- 838.
14 Favero M , Hoxha A , Frallonardo P , et al. Efficacy and safety of ultrasound-guided intra-articular glucocorticoid injection in erosive hand osteoarthritis[J]. Pain Med, 2021, 22 (5): 1229- 1232.
15 Aitken D , Laslett LL , Pan f , et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis: the HUMOR trial[J]. Osteoarthritis Cartilage, 2018, 26 (7): 880- 887.
16 Verbruggen G , Wittoek R , Vander-Cruyssen B , et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification[J]. Ann Rheum Dis, 2012, 71 (6): 891- 898.
17 Kloppenburg M , Ramonda R , Bobacz K , et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial[J]. Ann Rheum Dis, 2018, 77 (12): 1757- 1764.
18 Kloppenburg M , Peterfy C , Haugen IK , et al. Phase Ⅱ a, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis[J]. Ann Rheum Dis, 2019, 78 (3): 413- 420.
文章导航

/